Biotechnology and Its Applications — Complete Notes
Subject: Biology • Class: 12 • Unit: Biotechnology
Place in the exam pattern: Questions come from this chapter every year — Bt cotton and cry genes, RNAi, recombinant insulin, ADA gene therapy and ethical issues such as GEAC and the Basmati case are the most frequently asked parts.
1. Introduction — Where is Biotechnology Applied?
- Biotechnology uses living organisms, or systems derived from them, to make products and processes useful to humans. Genetically Modified Organisms (GMOs), produced through recombinant DNA technology, are its main tools.
- Its three major application areas are:
1. Agriculture — pest-resistant and stress-tolerant crops.
2. Medicine — recombinant medicines (insulin), gene therapy, molecular diagnosis.
3. Animal-based research (Transgenic animals) — biological products, disease study, vaccine and chemical safety testing.
- The Green Revolution succeeded in tripling food production, but it was not enough for the growing population. Excessive use of chemical fertilisers and pesticides is harmful to the environment and costly for farmers — so the use of genetically modified (GM) crops emerged as an alternative.
- Advantages of GM plants:
1. Greater tolerance to abiotic stresses (cold, drought, salt, heat).
2. Reduced dependence on chemical pesticides (pest resistance).
3. Help in reducing post-harvest losses.
4. Increased efficiency of plants in mineral usage from the soil.
5. Enhanced nutritional value of food — example: Golden rice (Vitamin-A enriched rice).
2. Applications in Agriculture — Pest Resistant Plants
One way to reduce the amount of chemical insecticides is to make the plant itself pest-resistant. The two main examples are Bt cotton and RNAi-based nematode-resistant tobacco.
2.1 Bt Cotton
- Certain bacteria produce proteins that kill specific insects but do not harm the bacteria themselves. The best known is the soil bacterium Bacillus thuringiensis
How does the protoxin become active toxin? (Remember the sequence)
1. The insect ingests the Bt protein (crystals).
2. The alkaline pH of the insect gut solubilises the crystals and converts the inactive protoxin into the active toxin.
3. The activated toxin binds to the surface of midgut epithelial cells and creates pores in them.
4. The pores cause the cells to swell and lyse, and the insect dies.
cry Genes and Their Pests (Most Frequently Asked Table)
| Gene | Protein | Pest Controlled |
|---|---|---|
| cryIAc | CryIAc | Cotton bollworms |
| cryIIAb | CryIIAb | Cotton bollworms |
| cryIAb | CryIAb | Corn borer |
- Bt toxins are specific — their activity depends on the insect group. They affect groups such as Lepidopterans (tobacco budworm, armyworm), Coleopterans (beetles) and Dipterans (flies, mosquitoes).
- How Bt cotton was made: the specific Bt toxin gene was isolated from Bacillus thuringiensis and introduced into the cotton plant. The resulting plant was pest-resistant, which greatly reduced the use of chemical insecticides.
- Remember: the gene name is written in lower case as cry, while the protein it produces is written starting with Cry.
2.2 RNA Interference (RNAi) and the Tobacco Experiment
- A nematode, Meloidegyne incognitia
The RNAi Experiment in Tobacco — Step by Step
1. Nematode-specific genes were introduced into the host plant (tobacco) using Agrobacterium vectors.
2. The introduced DNA produced both sense and anti-sense RNA in the plant cells.
3. Being complementary to each other, these two RNAs formed double-stranded RNA (dsRNA).
4. This dsRNA initiated RNAi and silenced the specific mRNA of the nematode.
5. Result: the parasite (nematode) could not survive in a transgenic host expressing specific interfering RNA — the plant protected itself from the parasite.
3. Applications in Medicine
Genetic engineering has had a deep impact on medicine — it has made mass production of safe and more effective therapeutic drugs possible. A major advantage of recombinant therapeutics is that they do not induce unwanted immunological responses, unlike similar products isolated from non-human sources, which often did. Worldwide, about 30 recombinant therapeutics have been approved for human use, of which 12 are being marketed in India (as per NCERT).
3.1 Genetically Engineered Insulin
- Insulin is taken at regular intervals for the treatment of adult-onset diabetes.
- The old method and its problems: Earlier, insulin was obtained from the pancreas of slaughtered cattle and pigs. In some patients, this foreign insulin caused allergy or other types of reactions. This raised a concern — would it ever be possible to make human insulin in bacteria in the laboratory?
- Structure of human insulin:
- Insulin is synthesised as a pro-hormone (pro-insulin), which contains an extra stretch called the C-peptide.
- During maturation, the C-peptide is removed — so mature insulin has no C-peptide.
- Mature insulin has two short polypeptide chains — chain A and chain B — linked together by disulphide bridges (not hydrogen bonds!).
Eli Lilly, 1983 — How was recombinant insulin made?
1. In 1983, the American company Eli Lilly prepared two DNA sequences corresponding to the A and B chains of human insulin.
2. These were introduced into the plasmids of E. coli
.3. Chain A and chain B were produced separately, then extracted.
4. The two chains were combined by creating disulphide bonds to form human insulin.
- The main challenge of producing insulin by recombinant technology was assembling insulin into its mature form.
- Insulin cannot be given orally, because it would be digested in the gastro-intestinal (GI) tract.
3.2 Gene Therapy
- Gene therapy is a collection of methods that allows correction of a gene defect diagnosed in a child or embryo. In it, genes are inserted into a person's cells and tissues to treat a disease.
- The essence of the method: a normal gene is delivered into the patient's cells, which takes over the function of the non-functional gene and compensates for its loss.
The First Clinical Case — ADA Deficiency (1990)
- The first clinical gene therapy was given in 1990 to a 4-year-old girl with Adenosine Deaminase (ADA) deficiency.
- What is ADA? This enzyme is crucial for the functioning of the immune system. Its deficiency makes the immune system non-functional.
- The disorder is caused by the deletion of the gene that produces ADA.
- Other treatment options and their limits:
1. In some children, the disorder can be treated by bone marrow transplantation.
2. In others, by enzyme replacement therapy — the patient is given injections of functional ADA.
3. However, both of these approaches are not completely curative.
Steps of Gene Therapy (Sequence)
1. Lymphocytes are taken from the patient's blood and grown in culture outside the body.
2. A functional ADA cDNA is introduced into these lymphocytes (using a retroviral vector).
3. These transformed lymphocytes are returned to the patient's body.
4. Limitation: These cells are not immortal, so the patient requires periodic infusion of such genetically engineered lymphocytes.
5. Towards a permanent cure: If the gene producing ADA is isolated from bone-marrow cells and introduced into cells at early embryonic stages, it could be a permanent cure.
3.3 Molecular Diagnosis
- For effective treatment of a disease, early diagnosis and understanding its pathophysiology are very important.
- Limitation of conventional methods: Using conventional diagnostic methods such as serum and urine analysis, early detection is not possible.
- Recombinant DNA technology, PCR and ELISA help in early diagnosis:
| Technique | Principle / Function |
|---|---|
| PCR (Polymerase Chain Reaction) | The presence of a pathogen can be detected by amplification of its nucleic acid even when its concentration is very low — even before the symptoms of the disease appear. PCR is now routinely used to detect HIV in suspected AIDS patients. It is also used to detect mutations in genes in suspected cancer patients and to identify many other genetic disorders. |
| rDNA Probe | A single-stranded DNA or RNA segment, tagged with a radioactive molecule, is allowed to hybridise with its complementary DNA in a clone of cells. Detection is then done by autoradiography — the clone having the mutated gene will not appear on the photographic film, because the probe does not have complementarity with the mutated gene. |
| ELISA | Based on the principle of antigen–antibody interaction. Infection by a pathogen can be detected by the presence of antigens (proteins, glycoproteins, etc.), or by detecting the antibodies synthesised against the pathogen. |
4. Transgenic Animals
- Animals whose DNA has been manipulated to possess and express an extra (foreign) gene are known as transgenic animals.
- Transgenic rats, rabbits, pigs, sheep, cows and fish have been produced, although over 95 per cent of all existing transgenic animals are mice.
Why are transgenic animals produced?
| Use | Details |
|---|---|
| 1. Normal physiology and development | To study how genes are regulated — for example, by introducing genes of the insulin-like growth factor and studying how the gene affects the body's development and biological factors. |
| 2. Study of diseases | Many transgenic animals are designed to serve as models for human diseases so that investigation of new treatments can be made possible — models for cancer, cystic fibrosis, rheumatoid arthritis and Alzheimer's. |
| 3. Biological products | Medicines required to treat certain human diseases can contain biological products, but such products are often expensive to make. Animals are made to produce useful biological products by introducing the portion of DNA (gene) that codes for that product. Example: the human protein α-1-antitrypsin is used to treat emphysema. Similar attempts have been made for the treatment of phenylketonuria (PKU) and cystic fibrosis. |
| 4. Vaccine safety | Transgenic animals are used to test the safety of vaccines before they are used on humans. Transgenic mice were used to test the safety of the polio vaccine — if found successful and reliable, they could replace the use of monkeys for this purpose. |
| 5. Chemical safety testing | Also called toxicity/safety testing. Transgenic animals are made that carry genes which make them more sensitive to toxic substances than non-transgenic animals. They are then exposed to the toxic substances and the effects studied in a shorter time. |
Rosie — The First Transgenic Cow
- In 1997, the first transgenic cow, Rosie, produced human protein-enriched milk (2.4 grams per litre).
- The milk contained human alpha-lactalbumin.
- It was a nutritionally more balanced product for human babies than natural cow milk.
5. Ethical Issues
- When humans manipulate living organisms, the question arises — can the ethics of such manipulation be ignored? There are certain ethical standards that control the legality of all human activities.
- The results of genetic modification, when organisms are released into the ecosystem, could be unpredictable.
- Therefore, the Indian Government has set up organisations such as GEAC (Genetic Engineering Approval Committee), which will make decisions regarding:
1. The validity of GM research, and
2. The safety of introducing GM organisms for public services.
Biopatents and Biopiracy
- Some companies are being granted patents for products and technologies that make use of genetic materials, plants and other biological resources — resources that have been identified, developed and conserved by the farmers and people of a particular region or country.
- The Basmati rice case:
- Rice grown in India is famous for its antiquity — Basmati is one of the varieties known for its aroma and flavour; India has an estimated 2,00,000 varieties of rice.
- In 1997, an American company got patent rights on Basmati rice through the US Patent and Trademark Office.
- This allowed the company to sell a 'new' variety of Basmati in the US and abroad. This 'new' variety had actually been derived from Indian farmer varieties — Indian Basmati was crossed with semi-dwarf varieties and claimed as an invention or novelty.
- Biopiracy means the exploitation of the bio-resources of a country by multinational companies and other organisations without proper authorisation from that country and its people, and without any compensatory benefit.
- Most industrial nations are financially rich but poor in biodiversity and traditional knowledge; in contrast, the developing and underdeveloped world is rich in bio-resources and related traditional knowledge — this imbalance is the root of the exploitation.
- Vigilance has grown in India too — the Indian Parliament has cleared the second amendment of the Indian Patents Bill, which takes such issues into consideration, including patent terms, emergency provisions and research and development initiative.
6. Applications — At a Glance (Summary Table)
| Area | Example | Key Fact |
|---|---|---|
| Pest-resistant crop | Bt cotton | cry genes of B. thuringiensis; protoxin activated at alkaline pH |
| Nematode resistance | RNAi tobacco | Meloidegyne incognitia; Agrobacterium vector; mRNA silencing by dsRNA |
| Recombinant medicine | Human insulin | Eli Lilly, 1983; A and B chains made separately in E. coli; disulphide bonds |
| Gene therapy | ADA deficiency | First case 1990, 4-year-old girl; lymphocytes are not immortal — periodic infusion |
| Molecular diagnosis | PCR, Probe, ELISA | PCR = amplification at low concentration; ELISA = antigen–antibody interaction |
| Transgenic animal | Rosie the cow | 1997; human alpha-lactalbumin, 2.4 g/L in milk |
| Ethical regulation | GEAC | Decides validity of GM research and safety of GM organisms |
| Biopiracy | Basmati case | 1997, US patent to an American company; derived from Indian varieties |
7. Important Facts — One-Liners (For Final Revision)
1. The bacterium that produces Bt toxin = Bacillus thuringiensis
; the toxin stays as an inactive protoxin in the crystals.2. The protoxin is activated by the alkaline pH of the insect gut — not by acidic pH.
3. The active Bt toxin makes pores in midgut cells → cells swell and lyse → the insect dies.
4. cryIAc and cryIIAb = cotton bollworms; cryIAb = corn borer.
5. The nematode that infects tobacco roots = Meloidegyne incognitia
.6. The vector used for gene transfer in RNAi = Agrobacterium
.7. RNAi is a method of cellular defence in all eukaryotic organisms; complementary dsRNA silences the mRNA.
8. Mature insulin has no C-peptide; chains A and B are joined by disulphide bridges.
9. Recombinant human insulin = Eli Lilly, 1983, A and B chains made separately in E. coli
.10. Old insulin came from the pancreas of cattle and pigs — it caused allergy in some patients.
11. Insulin cannot be given orally — it is digested in the GI tract.
12. First gene therapy = 1990, a 4-year-old girl, for ADA deficiency.
13. The ADA enzyme is crucial for the immune system; its deficiency is caused by deletion of the gene.
14. Lymphocytes in gene therapy are not immortal — so periodic infusion is needed.
15. A permanent cure is possible if the ADA gene is introduced into cells at early embryonic stages.
16. With PCR, diagnosis is possible even at a very low concentration of the pathogen — before symptoms appear.
17. The clone with the mutated gene does not appear on the autoradiography film — the probe has no complementarity with it.
18. ELISA is based on antigen–antibody interaction.
19. Over 95% of transgenic animals are mice.
20. Rosie (1997) = first transgenic cow; human alpha-lactalbumin, 2.4 g/L in milk.
21. Human α-1-antitrypsin is used to treat emphysema.
22. Transgenic mice were used to test the safety of the polio vaccine.
23. GEAC = Genetic Engineering Approval Committee — decides the validity and safety of GM research/organisms.
24. Basmati patent case = 1997, an American company, US Patent and Trademark Office.
25. Biopiracy = exploitation of bio-resources without authorisation or compensation.
26. Golden rice = Vitamin-A enriched GM rice.
8. Common Mistakes / Points to Note
1. Alkaline vs acidic pH: The Bt protoxin is activated by the alkaline pH of the insect gut. The 'acidic pH' statement was given as the false one in NEET 2024 — do not reverse it.
2. Matching the cry genes: Both cryIAc and cryIIAb are for cotton bollworms; cryIAb is for the corn borer. Do not pair IAc with the corn borer.
3. Insulin chains are joined by disulphide bonds, not hydrogen bonds — a favourite point in 'incorrect statement' questions.
4. C-peptide is present in pro-insulin, not in mature insulin; and in recombinant insulin, chains A and B are made separately — there is no processing of a pro-hormone.
5. dsRNA works in RNAi, not ssRNA — the complementary double-stranded RNA binds the mRNA and stops translation.
6. ADA deficiency affects the immune system — it is not a digestive or nervous disorder.
7. Bone marrow transplantation and enzyme replacement therapy are not complete cures for ADA deficiency — gene therapy is the corrective direction, but its effect is also temporary because the lymphocytes are not immortal.
8. Serum and urine analysis is not a technique of early diagnosis — rDNA technology, PCR and ELISA are.
9. GEAC's job is to decide the validity of GM research and the safety of introducing GM organisms; biopiracy does not mean use by native people — it means exploitation by outside companies/organisations without permission.
10. Rosie's protein is alpha-lactalbumin (2.4 g/L in milk); α-1-antitrypsin is a separate example used for emphysema — do not mix the two.
11. Gene therapy vs molecular diagnosis: Attempting to correct/amplify a gene in a person's tissue to treat a disease = gene therapy; techniques that identify a disease = molecular diagnosis — do not confuse them.
12. The Bt toxin does not harm the bacterium because it exists in the bacterium as an inactive protoxin — this point often appears in statement questions.
Next step: After these notes, take the 30-question Objective Quiz of this chapter — including previous years' questions, with an explanation for every question.

